Skip to main content
Premium Trial:

Request an Annual Quote

Great Basin Scientific Plans Reverse Stock Split

NEW YORK (GenomeWeb) – Great Basin Scientific late Wednesday announced it will implement a 1-for-80 reverse split of its common shares on Sept. 16.

At that time, every 80 shares will be consolidated into one newly issued and outstanding share, reducing the total number of outstanding shares to about 1 million from the current 78.4 million. Proportional adjustments will be made to outstanding preferred shares, stock options, warrants, and equity incentive plans, Great Basin said.

The company announced its shareholders had approved the stock split at a recent annual meeting. At the same meeting, however, the company failed to get a majority of stockholders to agree to a proposal increasing the number of authorized shares of Great Basin common stock to 350 million from 200 million.

On Sept. 7, Great Basin received a new delisting warning from the Nasdaq after its stock traded below $1 per share for 30 consecutive days, and after two previous warnings issued in October 2015 and again in April 2016. The firm will now have 180 days to maintain a minimum bid price of $1 for 10 consecutive days, and said it would seek shareholder approval for the reverse stock split as part of a plan to regain compliance with the listing rules.

Great Basin's shares are down 17 percent to $.10 in morning trading on the Nasdaq.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.